Microglial Dynamics in Neurodegenerative Disorders

Microglia, the resident immune sentinels of the central nervous system, continuously survey the brain parenchyma and respond to injury, infection and protein misfolding. Under homeostatic conditions, they support neuronal survival, sculpt synapses and clear cellular debris. In neurodegenerative disorders such as Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis, microglia undergo phenotypic shifts driven by local signals, adopting pro-inflammatory or alternative activation states. These states influence synaptic pruning, cytokine release and phagocytic activity. While early microglial responses may limit pathology by restricting protein aggregates and reinforcing blood–brain barrier integrity, chronic activation can exacerbate neuronal loss through excessive phagocytosis of stressed but viable neurons, impaired clearance of debris and the propagation of inflammatory cascades. Advances in single-cell transcriptomics and in vivo imaging have revealed spatial and temporal heterogeneity of microglial populations across disease stages, underscoring a complex interplay between microglial subtypes, systemic inflammation and neuronal vulnerability. Understanding this dynamic balance between protective and detrimental microglial functions is crucial for devising therapies that recalibrate immune responses to slow or halt neurodegeneration.

Research from Nature Portfolio

Recent studies have demonstrated a dual role for microglia in maintaining blood–brain barrier (BBB) integrity during systemic inflammation. In early stages, vessel-associated microglia express tight-junction proteins such as Claudin-5 and reinforce endothelial contacts to preserve barrier function. However, under sustained inflammatory conditions, microglia retract astrocytic end-feet and phagocytose perivascular structures, leading to increased BBB permeability. This shift from protective to deleterious action has been shown to influence peripheral immune infiltration and may accelerate neuronal dysfunction in chronic neurodegenerative settings.

Microglial Dynamics in Neurodegenerative Disorders publication trend

The graph below shows the total number of articles in microglial dynamics in neurodegenerative disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Microglia: Resident macrophage-like cells in the central nervous system that perform immune surveillance, debris clearance and synaptic remodelling.

Blood–brain barrier (BBB): A selective endothelial interface that restricts passage of cells and molecules from the circulation into the brain.

Phagocytosis: The process by which microglia engulf and digest cellular debris, pathogens or live cells marked for removal.

Neuroinflammation: An immune response within the central nervous system involving microglia and other glial cells, often marked by cytokine release and cellular recruitment.

P2Y6 receptor: A G-protein coupled receptor on microglia that is activated by extracellular uridine diphosphate and regulates phagocytic activity.

References

1. The microglial P2Y6 receptor as a therapeutic target for neurodegenerative diseases. Translational Neurodegeneration (2024).
2. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nature Communications (2019).
3. Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Frontiers in Cellular Neuroscience (2018).
4. Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy. Frontiers in Neuroscience (2021).